Loading…

Measuring patient reported outcomes in brachytherapy: Why we should do it and more importantly how

•A review of PROs in brachytherapy-especially prostate, gynaecologic and breast cancer.•To elaborate on the evidence that exists in the use of specific PROMs within prostate, breast and gynaecologic cancers.•Describing a novel rectal brachytherapy PROMs approach aiming to identify and resolve sympto...

Full description

Saved in:
Bibliographic Details
Published in:Clinical and translational radiation oncology 2024-11, Vol.49, p.100870, Article 100870
Main Authors: Spyrou, Aspazia, Martin, André-Guy, Hannoun-Lévi, Jean-Michel, Stewart, Alexandra
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c291t-5d7fdbb4a4b0870a9c59bd44c6956df634149df7e30833f50464f783deabf4cb3
container_end_page
container_issue
container_start_page 100870
container_title Clinical and translational radiation oncology
container_volume 49
creator Spyrou, Aspazia
Martin, André-Guy
Hannoun-Lévi, Jean-Michel
Stewart, Alexandra
description •A review of PROs in brachytherapy-especially prostate, gynaecologic and breast cancer.•To elaborate on the evidence that exists in the use of specific PROMs within prostate, breast and gynaecologic cancers.•Describing a novel rectal brachytherapy PROMs approach aiming to identify and resolve symptoms at an early stage. As the treatment for cancer improves and advances are made, the clinical focus is often on treatment response and survival. However, these are not the only factors which are important to patients. More patients are living longer after cancer treatment and therefore it is important that we can describe not only the treatment to patients but also what their life will be like during and after treatment. Patient reported outcomes (PROs) allow us to describe these. Although there are a range of patient reported outcome measures (PROMs) available to the clinician to assess these, the use of them in many areas of brachytherapy lags behind ideal levels. Brachytherapy has many features that differ to external beam radiotherapy (EBRT) yet the assessment of quality of life during and after treatment is much more scarce than EBRT. Brachytherapy is often used in the setting of organ preservation or in place of radical surgery, yet there is a paucity of quality of life data comparing the different treatment modalities. This review article will aim to elaborate on the evidence that exists in the use of specific PROMs within prostate, breast and gynaecologic cancers and describe the development of a novel PROMs approach in rectal brachytherapy which aims to identify and resolve symptoms at an early stage.
doi_str_mv 10.1016/j.ctro.2024.100870
format article
fullrecord <record><control><sourceid>elsevier_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_a852d478f7bf42caadac820ffa221c93</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2405630824001472</els_id><doaj_id>oai_doaj_org_article_a852d478f7bf42caadac820ffa221c93</doaj_id><sourcerecordid>S2405630824001472</sourcerecordid><originalsourceid>FETCH-LOGICAL-c291t-5d7fdbb4a4b0870a9c59bd44c6956df634149df7e30833f50464f783deabf4cb3</originalsourceid><addsrcrecordid>eNp9kF1LwzAUhosoOOb-gFf5A51pmn6JNzL8GEy8UbwMp8nJmrI1I8kc_fe2VsQrr87hwPtw3ieKrhO6TGiS37RLGZxdMsr4cKBlQc-iGeM0i_OUlud_9sto4X1LKU3KosrSbBbVLwj-6Ey3JQcIBrtAHB6sC6iIPQZp9-iJ6UjtQDZ9aNDBob8lH01PTkh8Y487RZQlJhDoFNlbh8TsRwB0YdeTxp6uogsNO4-LnzmP3h8f3lbP8eb1ab2638SSVUmIM1VoVdcceD1WgEpmVa04l3mV5UrnKU94pXSBQ4801RnlOddFmSqEWnNZp_NoPXGVhVYcnNmD64UFI74P1m0FuGDkDgWUGVO8KHUxRJkEUCBLRrUGxhJZpQOLTSzprPcO9S8voWKULloxShejdDFJH0J3UwiHlp8GnfByMCpRGYcyDG-Y_-Jfs4iMvA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Measuring patient reported outcomes in brachytherapy: Why we should do it and more importantly how</title><source>PubMed Central</source><creator>Spyrou, Aspazia ; Martin, André-Guy ; Hannoun-Lévi, Jean-Michel ; Stewart, Alexandra</creator><creatorcontrib>Spyrou, Aspazia ; Martin, André-Guy ; Hannoun-Lévi, Jean-Michel ; Stewart, Alexandra</creatorcontrib><description>•A review of PROs in brachytherapy-especially prostate, gynaecologic and breast cancer.•To elaborate on the evidence that exists in the use of specific PROMs within prostate, breast and gynaecologic cancers.•Describing a novel rectal brachytherapy PROMs approach aiming to identify and resolve symptoms at an early stage. As the treatment for cancer improves and advances are made, the clinical focus is often on treatment response and survival. However, these are not the only factors which are important to patients. More patients are living longer after cancer treatment and therefore it is important that we can describe not only the treatment to patients but also what their life will be like during and after treatment. Patient reported outcomes (PROs) allow us to describe these. Although there are a range of patient reported outcome measures (PROMs) available to the clinician to assess these, the use of them in many areas of brachytherapy lags behind ideal levels. Brachytherapy has many features that differ to external beam radiotherapy (EBRT) yet the assessment of quality of life during and after treatment is much more scarce than EBRT. Brachytherapy is often used in the setting of organ preservation or in place of radical surgery, yet there is a paucity of quality of life data comparing the different treatment modalities. This review article will aim to elaborate on the evidence that exists in the use of specific PROMs within prostate, breast and gynaecologic cancers and describe the development of a novel PROMs approach in rectal brachytherapy which aims to identify and resolve symptoms at an early stage.</description><identifier>ISSN: 2405-6308</identifier><identifier>EISSN: 2405-6308</identifier><identifier>DOI: 10.1016/j.ctro.2024.100870</identifier><language>eng</language><publisher>Elsevier B.V</publisher><subject>Brachytherapy ; Breast cancer ; Gynaecologic cancer ; patient reported outcomes (PROs) ; Prostate cancer ; Rectal cancer</subject><ispartof>Clinical and translational radiation oncology, 2024-11, Vol.49, p.100870, Article 100870</ispartof><rights>2024 The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c291t-5d7fdbb4a4b0870a9c59bd44c6956df634149df7e30833f50464f783deabf4cb3</cites><orcidid>0000-0001-9283-1327 ; 0000-0002-8177-3245</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Spyrou, Aspazia</creatorcontrib><creatorcontrib>Martin, André-Guy</creatorcontrib><creatorcontrib>Hannoun-Lévi, Jean-Michel</creatorcontrib><creatorcontrib>Stewart, Alexandra</creatorcontrib><title>Measuring patient reported outcomes in brachytherapy: Why we should do it and more importantly how</title><title>Clinical and translational radiation oncology</title><description>•A review of PROs in brachytherapy-especially prostate, gynaecologic and breast cancer.•To elaborate on the evidence that exists in the use of specific PROMs within prostate, breast and gynaecologic cancers.•Describing a novel rectal brachytherapy PROMs approach aiming to identify and resolve symptoms at an early stage. As the treatment for cancer improves and advances are made, the clinical focus is often on treatment response and survival. However, these are not the only factors which are important to patients. More patients are living longer after cancer treatment and therefore it is important that we can describe not only the treatment to patients but also what their life will be like during and after treatment. Patient reported outcomes (PROs) allow us to describe these. Although there are a range of patient reported outcome measures (PROMs) available to the clinician to assess these, the use of them in many areas of brachytherapy lags behind ideal levels. Brachytherapy has many features that differ to external beam radiotherapy (EBRT) yet the assessment of quality of life during and after treatment is much more scarce than EBRT. Brachytherapy is often used in the setting of organ preservation or in place of radical surgery, yet there is a paucity of quality of life data comparing the different treatment modalities. This review article will aim to elaborate on the evidence that exists in the use of specific PROMs within prostate, breast and gynaecologic cancers and describe the development of a novel PROMs approach in rectal brachytherapy which aims to identify and resolve symptoms at an early stage.</description><subject>Brachytherapy</subject><subject>Breast cancer</subject><subject>Gynaecologic cancer</subject><subject>patient reported outcomes (PROs)</subject><subject>Prostate cancer</subject><subject>Rectal cancer</subject><issn>2405-6308</issn><issn>2405-6308</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9kF1LwzAUhosoOOb-gFf5A51pmn6JNzL8GEy8UbwMp8nJmrI1I8kc_fe2VsQrr87hwPtw3ieKrhO6TGiS37RLGZxdMsr4cKBlQc-iGeM0i_OUlud_9sto4X1LKU3KosrSbBbVLwj-6Ey3JQcIBrtAHB6sC6iIPQZp9-iJ6UjtQDZ9aNDBob8lH01PTkh8Y487RZQlJhDoFNlbh8TsRwB0YdeTxp6uogsNO4-LnzmP3h8f3lbP8eb1ab2638SSVUmIM1VoVdcceD1WgEpmVa04l3mV5UrnKU94pXSBQ4801RnlOddFmSqEWnNZp_NoPXGVhVYcnNmD64UFI74P1m0FuGDkDgWUGVO8KHUxRJkEUCBLRrUGxhJZpQOLTSzprPcO9S8voWKULloxShejdDFJH0J3UwiHlp8GnfByMCpRGYcyDG-Y_-Jfs4iMvA</recordid><startdate>202411</startdate><enddate>202411</enddate><creator>Spyrou, Aspazia</creator><creator>Martin, André-Guy</creator><creator>Hannoun-Lévi, Jean-Michel</creator><creator>Stewart, Alexandra</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-9283-1327</orcidid><orcidid>https://orcid.org/0000-0002-8177-3245</orcidid></search><sort><creationdate>202411</creationdate><title>Measuring patient reported outcomes in brachytherapy: Why we should do it and more importantly how</title><author>Spyrou, Aspazia ; Martin, André-Guy ; Hannoun-Lévi, Jean-Michel ; Stewart, Alexandra</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c291t-5d7fdbb4a4b0870a9c59bd44c6956df634149df7e30833f50464f783deabf4cb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Brachytherapy</topic><topic>Breast cancer</topic><topic>Gynaecologic cancer</topic><topic>patient reported outcomes (PROs)</topic><topic>Prostate cancer</topic><topic>Rectal cancer</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Spyrou, Aspazia</creatorcontrib><creatorcontrib>Martin, André-Guy</creatorcontrib><creatorcontrib>Hannoun-Lévi, Jean-Michel</creatorcontrib><creatorcontrib>Stewart, Alexandra</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Clinical and translational radiation oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Spyrou, Aspazia</au><au>Martin, André-Guy</au><au>Hannoun-Lévi, Jean-Michel</au><au>Stewart, Alexandra</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Measuring patient reported outcomes in brachytherapy: Why we should do it and more importantly how</atitle><jtitle>Clinical and translational radiation oncology</jtitle><date>2024-11</date><risdate>2024</risdate><volume>49</volume><spage>100870</spage><pages>100870-</pages><artnum>100870</artnum><issn>2405-6308</issn><eissn>2405-6308</eissn><abstract>•A review of PROs in brachytherapy-especially prostate, gynaecologic and breast cancer.•To elaborate on the evidence that exists in the use of specific PROMs within prostate, breast and gynaecologic cancers.•Describing a novel rectal brachytherapy PROMs approach aiming to identify and resolve symptoms at an early stage. As the treatment for cancer improves and advances are made, the clinical focus is often on treatment response and survival. However, these are not the only factors which are important to patients. More patients are living longer after cancer treatment and therefore it is important that we can describe not only the treatment to patients but also what their life will be like during and after treatment. Patient reported outcomes (PROs) allow us to describe these. Although there are a range of patient reported outcome measures (PROMs) available to the clinician to assess these, the use of them in many areas of brachytherapy lags behind ideal levels. Brachytherapy has many features that differ to external beam radiotherapy (EBRT) yet the assessment of quality of life during and after treatment is much more scarce than EBRT. Brachytherapy is often used in the setting of organ preservation or in place of radical surgery, yet there is a paucity of quality of life data comparing the different treatment modalities. This review article will aim to elaborate on the evidence that exists in the use of specific PROMs within prostate, breast and gynaecologic cancers and describe the development of a novel PROMs approach in rectal brachytherapy which aims to identify and resolve symptoms at an early stage.</abstract><pub>Elsevier B.V</pub><doi>10.1016/j.ctro.2024.100870</doi><orcidid>https://orcid.org/0000-0001-9283-1327</orcidid><orcidid>https://orcid.org/0000-0002-8177-3245</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2405-6308
ispartof Clinical and translational radiation oncology, 2024-11, Vol.49, p.100870, Article 100870
issn 2405-6308
2405-6308
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_a852d478f7bf42caadac820ffa221c93
source PubMed Central
subjects Brachytherapy
Breast cancer
Gynaecologic cancer
patient reported outcomes (PROs)
Prostate cancer
Rectal cancer
title Measuring patient reported outcomes in brachytherapy: Why we should do it and more importantly how
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T23%3A50%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Measuring%20patient%20reported%20outcomes%20in%20brachytherapy:%20Why%20we%20should%20do%20it%20and%20more%20importantly%20how&rft.jtitle=Clinical%20and%20translational%20radiation%20oncology&rft.au=Spyrou,%20Aspazia&rft.date=2024-11&rft.volume=49&rft.spage=100870&rft.pages=100870-&rft.artnum=100870&rft.issn=2405-6308&rft.eissn=2405-6308&rft_id=info:doi/10.1016/j.ctro.2024.100870&rft_dat=%3Celsevier_doaj_%3ES2405630824001472%3C/elsevier_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c291t-5d7fdbb4a4b0870a9c59bd44c6956df634149df7e30833f50464f783deabf4cb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true